166 related articles for article (PubMed ID: 18450430)
21. QEEG Predictors of Treatment Response in Major Depressive Disorder- A Replication Study from Northwest India.
Singh A; Arun P; Singh GP; Kaur D; Kaur S
Clin EEG Neurosci; 2024 Mar; 55(2):176-184. PubMed ID: 36448183
[No Abstract] [Full Text] [Related]
22. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect.
Horacek J; Brunovsky M; Novak T; Tislerova B; Palenicek T; Bubenikova-Valesova V; Spaniel F; Koprivova J; Mohr P; Balikova M; Hoschl C
Psychol Med; 2010 Sep; 40(9):1443-51. PubMed ID: 19995475
[TBL] [Abstract][Full Text] [Related]
23. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
Wang G; Gislum M; Filippov G; Montgomery S
Curr Med Res Opin; 2015 Apr; 31(4):785-94. PubMed ID: 25650503
[TBL] [Abstract][Full Text] [Related]
24. Heart rate variability and cordance in rapid eye movement sleep as biomarkers of depression and treatment response.
Pawlowski MA; Gazea M; Wollweber B; Dresler M; Holsboer F; Keck ME; Steiger A; Adamczyk M; Mikoteit T
J Psychiatr Res; 2017 Sep; 92():64-73. PubMed ID: 28411417
[TBL] [Abstract][Full Text] [Related]
25. Can prefrontal theta cordance differentiate between depression recovery and dissimulation?
Kopecek M; Sos P; Brunovsky M; Bares M; Stopkova P; Krajca V
Neuro Endocrinol Lett; 2007 Aug; 28(4):524-6. PubMed ID: 17693989
[TBL] [Abstract][Full Text] [Related]
26. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Schatzberg A; Roose S
Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
[TBL] [Abstract][Full Text] [Related]
27. Frontal EEG predictors of treatment outcome in major depressive disorder.
Iosifescu DV; Greenwald S; Devlin P; Mischoulon D; Denninger JW; Alpert JE; Fava M
Eur Neuropsychopharmacol; 2009 Nov; 19(11):772-7. PubMed ID: 19574030
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Brain Functional Changes in High-Frequency Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression.
Ozekes S; Erguzel T; Sayar GH; Tarhan N
Clin EEG Neurosci; 2014 Oct; 45(4):257-261. PubMed ID: 24733717
[TBL] [Abstract][Full Text] [Related]
29. Does prior antidepressant treatment of major depression impact brain function during current treatment?
Hunter AM; Cook IA; Leuchter AF
Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212
[TBL] [Abstract][Full Text] [Related]
30. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.
Sáiz-Ruiz J; Ibáñez A; Díaz-Marsá M; Arias F; Padín J; Martín-Carrasco M; Montes JM; Ferrando L; Carrasco JL; Martín-Ballesteros E; Jordá L; Chamorro L
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1129-34. PubMed ID: 12452535
[TBL] [Abstract][Full Text] [Related]
33. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Bielski RJ; Ventura D; Chang CC
J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
[TBL] [Abstract][Full Text] [Related]
34. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
35. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.
Baskaran A; Farzan F; Milev R; Brenner CA; Alturi S; Pat McAndrews M; Blier P; Evans K; Foster JA; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Strother SC; Turecki G; Kennedy SH;
J Affect Disord; 2018 Feb; 227():542-549. PubMed ID: 29169123
[TBL] [Abstract][Full Text] [Related]
36. The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder.
Bares M; Novak T; Brunovsky M; Kopecek M; Höschl C
J Nerv Ment Dis; 2017 Aug; 205(8):618-626. PubMed ID: 27660994
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
38. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.
Cook IA; Leuchter AF; Morgan ML; Stubbeman W; Siegman B; Abrams M
J Psychiatr Res; 2005 Sep; 39(5):461-6. PubMed ID: 15992554
[TBL] [Abstract][Full Text] [Related]
39. Escitalopram versus venlafaxine XR in the treatment of depression.
Montgomery SA; Andersen HF
Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
